These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24676475)

  • 1. CIAPIN1 gene silencing enhances chemosensitivity in a drug-resistant animal model in vivo.
    Wang XM; Gao SJ; Guo XF; Sun WJ; Yan ZQ; Wang WX; Xu YQ; Lu D
    Braz J Med Biol Res; 2014 Apr; 47(4):273-8. PubMed ID: 24676475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down regulation of CIAPIN1 reverses multidrug resistance in human breast cancer cells by inhibiting MDR1.
    Lu D; Xiao Z; Wang W; Xu Y; Gao S; Deng L; He W; Yang Y; Guo X; Wang X
    Molecules; 2012 Jun; 17(6):7595-611. PubMed ID: 22717413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CIAPIN1 confers multidrug resistance by upregulating the expression of MDR-1 and MRP-1 in gastric cancer cells.
    Hao Z; Li X; Qiao T; Du R; Hong L; Fan D
    Cancer Biol Ther; 2006 Mar; 5(3):261-6. PubMed ID: 16410721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CIAPIN1 confers multidrug resistance through up-regulation of MDR-1 and Bcl-L in LoVo/Adr cells and is independent of p53.
    Zhang YF; Li XH; Shi YQ; Wu YY; Li N; He Q; Ji Q; Wang RQ; Yang SM; Fang DC
    Oncol Rep; 2011 Apr; 25(4):1091-8. PubMed ID: 21240465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax.
    Li X; Hong L; Zhao Y; Jin H; Fan R; Du R; Xia L; Luo G; Fan D
    Biochem Cell Biol; 2007 Dec; 85(6):741-50. PubMed ID: 18059532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-suppression of MDR1 (multidrug resistance 1) and GCS (glucosylceramide synthase) restores sensitivity to multidrug resistance breast cancer cells by RNA interference (RNAi).
    Zhang X; Li J; Qiu Z; Gao P; Wu X; Zhou G
    Cancer Biol Ther; 2009 Jun; 8(12):1117-21. PubMed ID: 19502811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells.
    Navarro G; Sawant RR; Biswas S; Essex S; Tros de Ilarduya C; Torchilin VP
    Nanomedicine (Lond); 2012 Jan; 7(1):65-78. PubMed ID: 22191778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting ETS1 with RNAi-based supramolecular nanoassemblies for multidrug-resistant breast cancer therapy.
    Wu M; Liu X; Jin W; Li Y; Li Y; Hu Q; Chu PK; Tang G; Ping Y
    J Control Release; 2017 May; 253():110-121. PubMed ID: 28302581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo.
    Shi Z; Liang YJ; Chen ZS; Wang XW; Wang XH; Ding Y; Chen LM; Yang XP; Fu LW
    Cancer Biol Ther; 2006 Jan; 5(1):39-47. PubMed ID: 16319528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reversal of multidrug resistance of gastric cancer cells by down-regulation of CIAPIN1 with CIAPIN1 siRNA].
    Li X; Fan R; Zou X; Hong L; Gao L; Jin H; Du R; He L; Xia L; Fan D
    Mol Biol (Mosk); 2008; 42(1):102-9. PubMed ID: 18389626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein arginine methyltransferase 1 may be involved in pregnane x receptor-activated overexpression of multidrug resistance 1 gene during acquired multidrug resistant.
    Li T; Kong AN; Ma Z; Liu H; Liu P; Xiao Y; Jiang X; Wang L
    Oncotarget; 2016 Apr; 7(15):20236-48. PubMed ID: 26934120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J; Fang X; Hao J; Sha X
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin.
    Qi X; Chang Z; Song J; Gao G; Shen Z
    Anticancer Drugs; 2011 Jul; 22(6):556-62. PubMed ID: 21637162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Tailored DNA Nanoplatform for Synergistic RNAi-/Chemotherapy of Multidrug-Resistant Tumors.
    Liu J; Song L; Liu S; Zhao S; Jiang Q; Ding B
    Angew Chem Int Ed Engl; 2018 Nov; 57(47):15486-15490. PubMed ID: 30288887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. siRNAs targeting multidrug transporter genes sensitise breast tumour to doxorubicin in a syngeneic mouse model.
    Tiash S; Chowdhury EH
    J Drug Target; 2019 Mar; 27(3):325-337. PubMed ID: 30221549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
    Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
    Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversing multidrug resistance by RNA interference through the suppression of MDR1 gene in human hepatoma cells.
    Chen XP; Wang Q; Guan J; Huang ZY; Zhang WG; Zhang BX
    World J Gastroenterol; 2006 Jun; 12(21):3332-7. PubMed ID: 16733848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer.
    Chang L; Hu Z; Zhou Z; Zhang H
    Cell Physiol Biochem; 2018; 48(1):16-28. PubMed ID: 30001527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of Bmi-1 gene by RNA interference enhances sensitivity to doxorubicin in breast cancer cells.
    Wu X; Liu X; Sengupta J; Bu Y; Yi F; Wang C; Shi Y; Zhu Y; Jiao Q; Song F
    Indian J Exp Biol; 2011 Feb; 49(2):105-12. PubMed ID: 21428211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversing multidrug-resistant by RNA interference through silencing MDR1 gene in human hepatocellular carcinoma cells subline Bel-7402/ADM.
    Sheng L; Xiong M; Li C; Meng X
    Pathol Oncol Res; 2014 Jul; 20(3):541-8. PubMed ID: 24327315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.